- Home
- CYBN
CYBN
Cybin Inc.
as 11-15-2024 4:00pm EST
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
| Founded: | 2019 | Country: | Canada |
| Employees: | N/A | City: | N/A |
| Market Cap: | 229.8M | IPO Year: | N/A |
| Target Price: | $45.50 | AVG Volume (30 days): | 334.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.98 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.50 - $21.66 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cybin Inc. News
CYBN Breaking Stock News: Dive into CYBN Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Cybin to Present 12-Month Phase 2 Data for CYB003 in Major Depressive Disorder on November 18, 2024
Business Wire
4 days ago
Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter Financial Results
Business Wire
17 days ago
Cybin to Participate at the 2024 Milken Institute Future of Health Summit
Business Wire
24 days ago
Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program
Business Wire
a month ago
Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024
Business Wire
2 months ago
Cybin Expands Clinical Team to Support CYB003 Phase 3 Program
Business Wire
2 months ago
Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
Business Wire
2 months ago
Cybin Provides Corporate Update on Upcoming Clinical Milestones
Compare CYBN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYBN Cybin Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.